Reports for BAYER INC
Company Name
BAYER INC
Totals |
||
Shortage reports |
85 |
|
Actual shortage: | 8 (9%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 10 (12%) | |
Resolved: | 67 (79%) | |
Discontinuation Reports |
23 |
|
To be discontinued: | 0 (0%) | |
Discontinued: | 22 (96%) | |
Reversed: | 1 (4%) | |
Late reports |
6 (6%) |
|
Overdue reports |
0 (0%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
XARELTO | 51.7MG | GRANULES FOR SUSPENSION | Resolved | 2024-01-11 | 2024-02-06 | 215608 |
XARELTO | 103.4MG | GRANULES FOR SUSPENSION | Resolved | 2022-08-24 | 2022-10-29 | 167663 |
XARELTO | 103.4MG | GRANULES FOR SUSPENSION | Resolved | 2023-06-29 | 2023-11-17 | 196862 |
VITRAKVI | 25MG | CAPSULE | Resolved | 2023-04-20 | 2023-06-10 | 189904 |
VITRAKVI | 100MG | CAPSULE | Resolved | 2023-04-28 | 2023-05-03 | 191158 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
CLIMARA PRO | 4.40MG 1.39MG | PATCH | Discontinued | 2017-11-06 | 2018-01-10 | 28316 |
JAYDESS | 13.5MG | INSERT (EXTENDED-RELEASE) | Discontinued | 2018-10-26 | 2019-01-04 | 65614 |
BONEFOS | 400MG | CAPSULE | Discontinued | 2017-11-09 | 2018-04-02 | 28705 |